Skip to content

Author

O. Alomarı

We have 6 of 119 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Intrasellar Cavernous Malformations: Two Case reports with A Systematic Review of Clinical Features, Surgical Management, and Outcomes.

ICMs are deceptive vascular lesions that require careful vigilance to minimize significant intraoperative hemorrhage and although complete resection is often technically challenging, tailored surgical strategies can achieve favorable functional outcomes.

H. Suslu, O. Alomarı, Halit Alioğlu et al. · 0 citations
Review Sep 2026

Non-invasive brain stimulation in amyotrophic lateral sclerosis: a systematic review and meta-analysis of transcranial direct current stimulation and transcranial magnetic stimulation.

BACKGROUND Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder with limited disease-modifying treatments. Noninvasive brain stimulation techniques have been investigated as potential neuromodulatory interventions targeting cortical hyperexcitability in ALS. OBJECTIVE To systematically eval...

B. Alrabadi, Hasan I. Matar, Natalie Bandak et al. · 0 citations
Review Aug 2026

Pure endoscopic resection of brainstem cavernous malformations: a systematic review of current evidence and future directions

Purely endoscopic resection of BCMs is a technically feasible and effective treatment modality, particularly for ventral and ventromedial pontine lesions, and offers high GTR rates and favorable neurological recovery while avoiding the brain retraction associated with open microsurgery.

O. Alomarı, A. Allahaweh, B. Alrabadi et al. · 0 citations
Review Aug 2026

Surgical outcomes and prognostic factors in traumatic optic neuropathy: a systematic review and meta-analysis of the endoscopic optic nerve decompression.

While pooled data supports surgical decompression as an effective intervention, future multicenter randomized controlled trials are essential to refine patient selection criteria, clarify the role of adjunctive steroids, and establish standardized protocols.

O. Alomarı, M. Mokresh, Beyzanur Güney et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.